STAGE IV INTRAHEPATIC BILE DUCT CANCER AJCC V8
Clinical trials for STAGE IV INTRAHEPATIC BILE DUCT CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV INTRAHEPATIC BILE DUCT CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV INTRAHEPATIC BILE DUCT CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug combo targets Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests an experimental drug called BAY 1895344 combined with standard chemotherapy (cisplatin, with or without gemcitabine) in people with advanced solid tumors, especially urothelial cancer. The goal is to find the best dose and see how safe the combination…
Matched conditions: STAGE IV INTRAHEPATIC BILE DUCT CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New chemo mist targets abdominal cancer with fewer side effects
Disease control TerminatedThis early-stage trial tests a technique called PIPAC, which turns chemotherapy into a fine mist and sprays it directly into the abdomen during a keyhole surgery. The goal is to see if this method is safe and reduces side effects for people with biliary tract cancer that has spre…
Matched conditions: STAGE IV INTRAHEPATIC BILE DUCT CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC